Juan Pablo Frias
Known title: Chief Medical OfficerCIK: 0001990665
Associated companies
Transaction History
| BMEA | ▲ Buy | Grant | 349 | $3K | 5/31/2024 | View on chart |
| BMEA | ▲ Buy | Grant | 349 | $3K | 5/31/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Biomea Fusion Cancels Equity Offering, Shares Drop 19%
Biomea Fusion announced the termination of its proposed public equity offering, citing market conditions. The cancellation removes expected dilution relief and leaves the company with near‑term runway pressure. Following the news, the stock fell about 19% in after‑hours trading. The development occurs amid broader health‑care stock activity.
Biomea Fusion Cancels Equity Offering, Shares Drop 19%. Biomea Fusion announced the termination of its proposed public equity offering, citing market conditions. The cancellation removes expected dilution relief and leaves the company with near‑term runway pressure. Following the news, the stock fell about 19% in after‑hours trading. The development occurs amid broader health‑care stock activity.